CASE REPORT article

Front. Oncol.

Sec. Breast Cancer

Volume 15 - 2025 | doi: 10.3389/fonc.2025.1495731

This article is part of the Research TopicAdvances in Tumor Microenvironment, Immunology and Immunotherapy of Breast CancerView all 10 articles

Case Report of Concurrent Ulcerative Colitis and Bilateral Breast Cancer: A Literature Review of the Bidirectional Association Between Autoimmune Diseases and Breast Cancer

Provisionally accepted
Xiao  QiXiao Qi1Miao  ZhangMiao Zhang1Jinhong  ZhuJinhong Zhu2Huaqing  WangHuaqing Wang1*
  • 1Tianjin Union Medical Centre, Nankai University, Tianjin, China
  • 2School of Medicine, Nankai University, Tianjin, China

The final, formatted version of the article will be published soon.

A 58-year old female with bilateral breast cancer developed unexpected hematochezia at a frequency of approximately 10 episodes per day following adjuvant chemotherapy, with the emergency endoscopy reporting superficial ulcers throughout the entire colon, suggesting a diagnosis of ulcerative colitis. Given the absence of preexisting autoimmune history or detectable autoantibodies, we supposed that the onset of UC being closely related to the chemotherapy. The complex bidirectional relationship between autoimmune rheumatic diseases and cancer continues to be elucidated. Variations in autoimmune disease types, duration, and specific clinical/laboratory features may modulate cancer risk—either increasing or decreasing susceptibility to certain malignancies. These associations could potentially inform type-specific cancer screening strategies. Furthermore, the widespread use of immune checkpoint inhibitors across multiple tumor types, along with their associated inflammatory syndromes, has significant implications for the development and management of autoimmune rheumatic diseases. Herein we reported this case which could be one of the few bilateral breast cancer cases to be reported with ulcerative colitis and conducted a literature review of the bidirectional association of breast cancer and autoimmune diseases.

Keywords: ulcerative colitis, Bilateral breast cancer, Adjuvant chemotherapy, target therapy, autoimmune disease

Received: 13 Sep 2024; Accepted: 19 May 2025.

Copyright: © 2025 Qi, Zhang, Zhu and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Huaqing Wang, Tianjin Union Medical Centre, Nankai University, Tianjin, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.